A jury in Suffolk County, working through the lunch hour last Thursday, took only one hour and 40 minutes to clear the makers of pHisoHex, of a product liability claim that the acne soap — once used by millions of teenagers — had caused epilepsy and mental retardation when used on a two-week-old infant.
The speed with which the six-member jury reached its unanimous verdict came as a surprise in view of the case’s lengthy history and the intensity with which it was fought. The case was the first to go to trial involving the safety of pHisoHex, though there may have been at least seven settlements involving its use.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
